HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 T-CELL TROPISM IS DETERMINED BY EVENTS PRIOR TO PROVIRUS FORMATION

被引:112
|
作者
CANN, AJ
ZACK, JA
GO, AS
ARRIGO, SJ
KOYANAGI, Y
GREEN, PL
KOYANAGI, Y
PANG, S
CHEN, ISY
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90024
[2] UNIV CALIF LOS ANGELES,SCH MED,DEPT MICROBIOL & IMMUNOL,LOS ANGELES,CA 90024
[3] JONSSON COMPREHENS CANC CTR,LOS ANGELES,CA 90024
关键词
D O I
10.1128/JVI.64.10.4735-4742.1990
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:4735 / 4742
页数:8
相关论文
共 50 条
  • [1] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TROPISM FOR HUMAN MACROPHAGES
    COLLMAN, R
    [J]. PATHOBIOLOGY, 1992, 60 (04) : 213 - 218
  • [2] HELPER T-CELL RESPONSES IN CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ROILIDES, E
    CLERICI, M
    DEPALMA, L
    RUBIN, M
    PIZZO, PA
    SHEARER, GM
    [J]. JOURNAL OF PEDIATRICS, 1991, 118 (05): : 724 - 730
  • [3] MACROPHAGE TROPISM DETERMINANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INVIVO
    WESTERVELT, P
    TROWBRIDGE, DB
    EPSTEIN, LG
    BLUMBERG, BM
    LI, YX
    HAHN, BH
    SHAW, GM
    PRICE, RW
    RATNER, L
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (04) : 2577 - 2582
  • [4] VIRAL DETERMINANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 T-CELL OR MACROPHAGE TROPISM, CYTOPATHOGENICITY, AND CD4 ANTIGEN MODULATION
    CHENGMAYER, C
    QUIROGA, M
    TUNG, JW
    DINA, D
    LEVY, JA
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (09) : 4390 - 4398
  • [5] THE RRE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CONTRIBUTES TO CELL-TYPE-SPECIFIC VIRAL TROPISM
    DAYTON, ET
    KONINGS, DAM
    LIM, SY
    HSU, RKS
    BUTINI, L
    PANTALEO, G
    DAYTON, AI
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (05) : 2871 - 2878
  • [6] THE REGION OF THE ENVELOPE GENE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESPONSIBLE FOR DETERMINATION OF CELL TROPISM
    CANN, AJ
    CHURCHER, MJ
    BOYD, M
    OBRIEN, W
    ZHAO, JQ
    ZACK, J
    CHEN, ISY
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (01) : 305 - 309
  • [7] ADENOSINE-DEAMINASE ISOENZYME LEVELS IN PATIENTS WITH HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-1 AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTIONS
    TSUBOI, I
    SAGAWA, K
    SHICHIJO, S
    YOKOYAMA, MM
    OU, DW
    WIDERHOLD, MD
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (05) : 626 - 630
  • [8] NEUTRALIZATION SENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS DETERMINED IN PART BY THE CELL IN WHICH THE VIRUS IS PROPAGATED
    SAWYER, LSW
    WRIN, MT
    CRAWFORDMIKSZA, L
    POTTS, B
    WU, YM
    WEBER, PA
    ALFONSO, RD
    HANSON, CV
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (03) : 1342 - 1349
  • [9] ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS AND HUMAN T-CELL LEUKEMIA-VIRUS TYPE-1 IN JAPANESE PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    TOBINAI, K
    MINATO, K
    SHIMOYAMA, M
    KAWATANI, T
    KURIMURA, T
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1986, 77 (12): : 1207 - 1210
  • [10] FATE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRUS IN INFECTED-CELLS - A ROLE FOR VPR
    PLANELLES, V
    BACHELERIE, F
    JOWETT, JBM
    HAISLIP, A
    XIE, YM
    BANOONI, P
    MASUDA, T
    CHEN, ISY
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (09) : 5883 - 5889